Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11708329
Inhibitors of the WNT/beta-catenin pathway
granted -
US 11708352
Anti-cancer compounds
granted -
US 11707550
Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use
granted -
US 11701384
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
granted -
US 11702657
TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma
granted -
US 11702656
Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders
granted -
US 11702480
Engineered antibodies and uses thereof
granted -
US 11702630
In vitro methods of differentiating stem cells into neurons and neurons generated using the same
granted -
US 11702442
Cyclic dinucleotide compounds as sting agonists
granted -
US 11696929
Methods and systems for conserving highly expanded cells
granted -
US 11699503
Methods of identifying and treating patient populations amenable to cancer immunotherapy
granted -
US 11696904
Prodrug for therapeutic applications
granted -
US 11696898
Halogenated ether compounds and methods of inducing anesthesia
granted -
US 11690837
Methods of improving cell-based therapy
granted -
US 11692229
Fast diagnosis and personalized treatments for acne
granted -
US 11692184
Thermostable RNA-guided endonucleases and methods of use thereof
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11684585
Nanoscale coatings for encapsulation of biological entities
granted -
US 11684609
Compounds and methods for treating an epileptic disorder
granted -
US 11685909
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 11684614
Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
granted -
US 11679103
Multi-targeting agents for Alzheimer's disease therapy
granted -
US 11680249
Adeno-associated virus capsid variants and methods of use thereof
granted -
US 11680244
Method for generating human dendritic cells for immunotherapy
granted